Research summaries for everyoneNot medical advice
GHK-Cu research reference vial, Elevated Pharma

Research reference · Skin & Collagen

GHK-Cu

GHK-Cu is the copper complex of the tripeptide glycyl-histidyl-lysine. It is widely studied in skin and wound models and used in topical cosmetics.

Published by Elevated Pharma ·

Skin & CollagenPreclinical literature

Identity

What is GHK-Cu?

A copper(II) complex of the Gly-His-Lys tripeptide, also called copper tripeptide-1.

Research context

What has GHK-Cu been studied for?

Evidence includes laboratory and animal wound studies, gene-expression work and small topical human studies. A 2026 review focuses on copper speciation and formulation quality.

Evidence boundary

What does the research not show?

Preclinical findings do not establish clinical benefit, and topical findings do not transfer to injected material.

U.S. status · November 7, 2026

Is GHK-Cu FDA-approved?

FDA removed injectable GHK-Cu from its Category 2 compounding list in April 2026 and scheduled it for advisory-committee review before the end of February 2027. It is not covered by the October 2026 HHS interim policy.

Research updates

What’s new

Dated developments for GHK-Cu, newest first. See all research updates.

  1. Expert caution on clinical claims

    A commentary in Aesthetic Surgery Journal warns that mechanistic plausibility is not clinical validation.

    Read the source
  2. Category 2 removals

    FDA announced the removal of 12 peptide substances from its Category 2 compounding list, effective about April 22, 2026. Removal is not approval.

    Read the source

Key studies

The main GHK-Cu research

Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.

Search all 152 PubMed records for GHK-Cu · Counts and selections checked November 7, 2026.

Reference identifiers

GHK-Cu identity data

Database identity describes the reference substance, not any specific material or lot.

Primary name
GHK-Cu
Also indexed as
Copper tripeptide-1 / Copper glycyl-L-histidyl-L-lysine
Sequence
Gly-His-Lys
Molecular formula
C14H21CuN6O4-
Molecular mass
400.9 g/mol
PubChem CID
139035031

Official & primary sources

Regulatory and database records

Citation does not imply an Elevated Pharma partnership or endorsement.